Condition
Lymphoblastic Lymphoma, Childhood
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 3 (1)
Trial Status
Unknown1
Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04043494Phase 3RecruitingPrimary
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT03817320Phase 1Active Not Recruiting
PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
NCT03971318Unknown
A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL
Showing all 3 trials